Shareholders Equity and Capital Stock (Details 7) |
10 Months Ended | 12 Months Ended |
|---|---|---|
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
|
| Aggregate Intrinsic Value | $ 2,277,068 | |
| Warrants | ||
| Exercise price | $ / shares | $ 1.16 | $ 1.16 |
| Number of warrants | shares | 24,368,530 | 24,368,530 |
| Remaining contractual life (years) | 1 year 7 months 6 days | |
| Aggregate Intrinsic Value | $ 1,794,930 | |
| Exercise price $0.75 | ||
| Exercise price | $ / shares | $ 0.75 | $ 0.75 |
| Number of warrants | shares | 7,638,000 | 7,638,000 |
| Remaining contractual life (years) | 7 months 6 days | |
| Aggregate Intrinsic Value | $ 1,794,930 | |
| Expiry | Aug. 04, 2022 | |
| Exercise price $1.35 | ||
| Exercise price | $ / shares | $ 1.35 | $ 1.35 |
| Number of warrants | shares | 16,730,530 | 16,730,530 |
| Remaining contractual life (years) | 2 years 1 month 6 days | |
| Aggregate Intrinsic Value | $ 0 | |
| Expiry | Feb. 04, 2024 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|